Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis

Neurology

Volumn 77, Issue 24, 2011, Pages 2089-2096

  Riddell, C A ^a   Zhao, Y ^b   Li, D K B ^a   Petkau, A J ^a   Riddehough, A ^b   Cutter, G R ^c   Traboulsee, A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENERCEPT;

ADULT; ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTRAST ENHANCING LESION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 84862907806     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823d762d     Document Type: Article

References (9)

1. Li DK, Li MJ, Traboulsee A, et al. The use of MRI as an outcome measure in clinical trials. Adv Neurol 2006;98:203-226.
2. Grossman RI, Gonzales-Scarano F, Atlas SW, et al. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986;169:117-122.
3. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine enhancing MRI lesions. Ann Neurol 1993;33:480-489. (Pubitemid 23143031)
4. Frank JA, McFarland HF. How to participate in a multiple sclerosis clinical trial. Neuroimaging Clin N Am 2000;10:817-830. (Pubitemid 32391270)
5. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999;53:457-465.
6. Zhao Y, Petkau AJ, Traboulsee A, et al. Does MRI lesion activity regress in secondary progressive multiple sclerosis? Mult Scler 2010;16:434-442.
7. McCullagh PJ, Nelder JA. Generalized Linear Models, 2nd ed. Boca Raton: Chapman & Hall/CRC; 1991.
8. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data, 2nd ed. New York: Oxford University Press; 2002.
9. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995;311:485.